Dr. Giacinto d’Ettorre has been appointed as a new board member of BIOGENERA. Dr. D’Ettorre has many years of experience in the pharmaceutical industry at management levels. He currently serves as chief financial officer (CFO) at a leading pharmaceutical company, and previously served as CFO of Europe at SHIRE (now merged into TAKEDA), and CFO of Brazil for ROCHE.